statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UCG / Contributor / Getty Images

 Key TakeawaysThe S&P 500 was little changed, adding 0.2% on Friday, May 10, 2024, as data showed a steep drop in consumer sentiment in May.Shares of Mettler...

S&P 500 Gains and Losses Today: Akamai Technologies Tumbles on Weak Guidance

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced financial results for the three...

Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today released its 2023 Sustainability Report...

Insulets 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced plans to release its financial...

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024

Key Insights The projected fair value for Insulet is US$183 based on 2 Stage Free Cash Flow to Equity With US$171 share...

Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)

Insulet (PODD) closed the last trading session at $169.18, gaining 3.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street...

Wall Street Analysts See a 38.87% Upside in Insulet (PODD): Can the Stock Really Move This High?

Insulet: Insulating Patients, Investors Still Have To Wait...

Insulet: Insulating Patients, Investors Still Have To Wait

Shares of Insulet Co. (NASDAQ:PODD  Get Free Report) have been given a consensus rating of Moderate Buy by the sixteen analysts that are covering the company, MarketBeat Ratings...

Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of "Moderate Buy" from Analysts

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced that Ana Maria Chadwick has been...

Insulet Appoints Ana Maria Chadwick as Chief Financial Officer

In afternoon trading on Wednesday, Healthcare stocks are the worst performing sector, showing a 0.7% loss. Within that group, Insulet Corp (PODD) and Moderna Inc (MRNA) are two of the days...

Wednesday Sector Laggards: Healthcare, Utilities

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Watchers	1,722
52-Wk Low	$125.82
52-Wk High	$331.65

Volume	208,944.00
52-Wk High	$331.65
52-Wk Low	$125.82

Period	Estimated	Reported	Surprise	Result
Q2'24	$0.56	--	--	N/A
Q1'24	$0.40	$0.73	81.95%	BEAT
Q4'23	$0.65	$1.44	120.52%	BEAT
Q3'23	$0.40	$0.74	83.63%	BEAT
Q2'23	$0.26	$0.39	48.59%	BEAT

PODD Insulet Corporation

About

Feed

News

Sentiment

Earnings

Fundamentals